Levosimendan Administration and Outcome in Cardiac Surgery

To assess the effects on outcome of levosimendan with respect to timing of its administration on the postoperative course of high-risk cardiac surgery patients in a retrospective observational study.

Inclusion Criteria:

• patients undergoing cardiac surgery between 2006 and 2013
• levosimendan administration within 24 hours of postoperative ICU admission

Exclusion Criteria:

• patients younger than 18